Robert L. Cohen

2.6k total citations · 1 hit paper
23 papers, 2.2k citations indexed

About

Robert L. Cohen is a scholar working on Cancer Research, Hematology and Molecular Biology. According to data from OpenAlex, Robert L. Cohen has authored 23 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 9 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Robert L. Cohen's work include Protease and Inhibitor Mechanisms (10 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Peptidase Inhibition and Analysis (4 papers). Robert L. Cohen is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Peptidase Inhibition and Analysis (4 papers). Robert L. Cohen collaborates with scholars based in United States, United Kingdom and France. Robert L. Cohen's co-authors include Marc A. Shuman, David A. Lawrence, Craig Crowley, Arthur D. Levinson, Kenneth J. Hillan, David Botstein, Austin Gurney, Audrey D. Goddard, Margaret Roy and Guo Jun Liu and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert L. Cohen

23 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

1998 645 citations Robert Pitti, Scot A. Marsters et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert L. Cohen United States	14	1.2k	840	528	449	403	23	2.2k
Minji Jo United States	23	1.6k 1.3×	902 1.1×	796 1.5×	444 1.0×	239 0.6×	33	2.5k
Liliana Guédez United States	18	810 0.7×	921 1.1×	663 1.3×	280 0.6×	299 0.7×	22	1.8k
Angela Garofalo Italy	23	985 0.8×	687 0.8×	807 1.5×	345 0.8×	188 0.5×	35	2.0k
Maria Teresa Masucci Italy	15	713 0.6×	1.0k 1.2×	779 1.5×	679 1.5×	468 1.2×	28	2.2k
Vicki L. Rothman United States	25	1.4k 1.2×	786 0.9×	383 0.7×	180 0.4×	284 0.7×	48	2.1k
Kazushi Shigemasa Japan	27	840 0.7×	441 0.5×	636 1.2×	271 0.6×	249 0.6×	50	1.8k
Pia Ragno Italy	26	761 0.6×	937 1.1×	448 0.8×	312 0.7×	476 1.2×	53	1.8k
Marya F. McCarty United States	29	2.0k 1.7×	869 1.0×	1.1k 2.1×	436 1.0×	137 0.3×	37	3.0k
Yasmin Akbarali United States	17	1.1k 0.9×	264 0.3×	420 0.8×	382 0.9×	432 1.1×	17	1.8k
Douglas Armellino United States	15	1.3k 1.1×	401 0.5×	738 1.4×	247 0.6×	156 0.4×	18	2.3k

Countries citing papers authored by Robert L. Cohen

Since Specialization

Citations

This map shows the geographic impact of Robert L. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Cohen more than expected).

Fields of papers citing papers by Robert L. Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Cohen. The network helps show where Robert L. Cohen may publish in the future.

Co-authorship network of co-authors of Robert L. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Cohen. A scholar is included among the top collaborators of Robert L. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Cohen. Robert L. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bernstein, Nicholas, Michael Spencer Chapman, Nicholas Williams, et al.. (2024). Analysis of somatic mutations in whole blood from 200,618 individuals identifies pervasive positive selection and novel drivers of clonal hematopoiesis. Nature Genetics. 56(6). 1147–1155. 36 indexed citations

Sorokin, Elena P., Nicolas Basty, Brandon Whitcher, et al.. (2022). Analysis of MRI-derived spleen iron in the UK Biobank identifies genetic variation linked to iron homeostasis and hemolysis. The American Journal of Human Genetics. 109(6). 1092–1104. 13 indexed citations

Settleman, Jeff & Robert L. Cohen. (2016). Communication in Drug Development: “Translating” Scientific Discovery. Cell. 164(6). 1101–1104. 10 indexed citations

Cohen, Robert L. & Jeff Settleman. (2014). From Cancer Genomics to Precision Oncology—Tissue’s Still an Issue. Cell. 157(7). 1509–1514. 24 indexed citations

Cohen, Robert L., et al.. (2014). Failure to improve a thin endometrium in the late proliferative phase with uterine infusion of granulocyte-colony stimulating factor. Clinical and Experimental Obstetrics & Gynecology. 41(4). 473–475. 11 indexed citations

Lévy, Corinne, Fouad Madhi, Robert L. Cohen, et al.. (2014). Épidémiologie récente des méningites à méningocoque en pédiatrie Observatoire GPIP/ACTIV. Archives de Pédiatrie. 21(5). 309–310. 1 indexed citations

Cohen, Robert L., et al.. (2005). Caspase Inhibitors and Myocardial Apoptosis. International Anesthesiology Clinics. 43(2). 77–89. 10 indexed citations

Pitti, Robert, Scot A. Marsters, David A. Lawrence, et al.. (1998). Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 396(6712). 699–703. 645 indexed citations breakdown →

Pham, Christine D., Timothy P. L. Roberts, Nick van Bruggen, et al.. (1998). Magnetic Resonance Imaging Detects Suppression of Tumor Vascular Permeability After Administration of Antibody to Vascular Endothelial Growth Factor. Cancer Investigation. 16(4). 225–230. 173 indexed citations

10.

Pennica, Diane, Todd A. Swanson, James W. Welsh, et al.. (1998). WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proceedings of the National Academy of Sciences. 95(25). 14717–14722. 437 indexed citations

11.

Higazi, Abd Al‐Roof, Joseph F. Aceto, Douglas A. Kniss, et al.. (1996). Unesterified Long Chain Fatty Acids Inhibit the Binding of Single Chain Urokinase to the Urokinase Receptor. Biochemistry. 35(21). 6884–6890. 8 indexed citations

12.

Bianchi, Elisabetta, Robert L. Cohen, Aihua Dai, et al.. (1995). Immunohistochemical localization of the plasminogen activator inhibitor‐1 in breast cancer. International Journal of Cancer. 60(5). 597–603. 56 indexed citations

13.

Higazi, Abd Al‐Roof, Robert L. Cohen, Jack Henkin, et al.. (1995). Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor. Journal of Biological Chemistry. 270(29). 17375–17380. 89 indexed citations

14.

Shuman, Marc A., et al.. (1995). Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cells. International Journal of Cancer. 60(4). 501–506. 132 indexed citations

15.

Nykjær, Anders, Lars Kjøller, Robert L. Cohen, et al.. (1994). Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.. Journal of Biological Chemistry. 269(41). 25668–25676. 123 indexed citations

16.

Mizukami, Ikuko F., B A Garni-Wagner, Monica Liebert, et al.. (1994). Immunologic Detection of the Cellular Receptor for Urokinase Plasminogen Activator. Clinical Immunology and Immunopathology. 71(1). 96–104. 32 indexed citations

17.

Brown, J. Martin, Robert L. Cohen, & Donald A. Chambers. (1992). Effects of Retinoic Acid on Plasminogen Activators in Murine Epidermal Cell Culture. Annals of the New York Academy of Sciences. 667(1). 50–51. 3 indexed citations

18.

Cohen, Robert L., J Niclas, Tze-Chein Wun, et al.. (1989). Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. Journal of Biological Chemistry. 264(14). 8375–8383. 29 indexed citations

19.

Reinert, Philippe, et al.. (1987). [Autoimmune neutropenia disclosing AIDS in a child].. PubMed. 138(6). 416–8. 2 indexed citations

20.

Cohen, Robert L. & P. A. Webb. (1952). Nystatin, a coccidioidocidal antibiotic.. PubMed. 69(10). 414–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact